BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 21874003)

  • 1. Germline mutations in BAP1 predispose to melanocytic tumors.
    Wiesner T; Obenauf AC; Murali R; Fried I; Griewank KG; Ulz P; Windpassinger C; Wackernagel W; Loy S; Wolf I; Viale A; Lash AE; Pirun M; Socci ND; Rütten A; Palmedo G; Abramson D; Offit K; Ott A; Becker JC; Cerroni L; Kutzner H; Bastian BC; Speicher MR
    Nat Genet; 2011 Aug; 43(10):1018-21. PubMed ID: 21874003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.
    Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P
    J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline BRCA1-associated protein 1 mutation presenting as BAP1 inactivated melanocytic nevi in a child of a father with fatal paraganglioma.
    Watchorn RE; Calonje E; Taibjee SM
    Pediatr Dermatol; 2018 Sep; 35(5):e316-e318. PubMed ID: 29974497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z; Buljan M; Busam KJ
    J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome.
    Busam KJ; Wanna M; Wiesner T
    JAMA Dermatol; 2013 Mar; 149(3):335-9. PubMed ID: 23552620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.
    Wiesner T; Murali R; Fried I; Cerroni L; Busam K; Kutzner H; Bastian BC
    Am J Surg Pathol; 2012 Jun; 36(6):818-30. PubMed ID: 22367297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation.
    Gerami P; Yélamos O; Lee CY; Obregon R; Yazdan P; Sholl LM; Guitart GE; Njauw CN; Tsao H
    JAMA Dermatol; 2015 Nov; 151(11):1235-9. PubMed ID: 26154183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer.
    McDonnell KJ; Gallanis GT; Heller KA; Melas M; Idos GE; Culver JO; Martin SE; Peng DH; Gruber SB
    Cancer Genet; 2016 Mar; 209(3):75-81. PubMed ID: 26774355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights into the BAP1-inactivated melanocytic tumor.
    Donati M; Martinek P; Steiner P; Grossmann P; Vanecek T; Kastnerova L; Kolm I; Baneckova M; Donati P; Kletskaya I; Kalmykova A; Feit J; Blasch P; Szilagyi D; Baldi A; Persichetti P; Crescenzi A; Michal M; Kazakov DV
    Mod Pathol; 2022 May; 35(5):664-675. PubMed ID: 34857909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
    Njauw CN; Kim I; Piris A; Gabree M; Taylor M; Lane AM; DeAngelis MM; Gragoudas E; Duncan LM; Tsao H
    PLoS One; 2012; 7(4):e35295. PubMed ID: 22545102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
    Yélamos O; Navarrete-Dechent C; Marchetti MA; Rogers T; Apalla Z; Bahadoran P; Blázquez-Sánchez N; Busam K; Carrera C; Dusza SW; de la Fouchardière A; Ferrara G; Gerami P; Kittler H; Lallas A; Malvehy J; Millán-Cayetano JF; Nelson KC; Quan VL; Puig S; Stevens H; Thomas L; Marghoob AA
    J Am Acad Dermatol; 2019 Jun; 80(6):1585-1593. PubMed ID: 30244062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The morphologic spectrum of germline-mutated BAP1-inactivated melanocytic tumors includes lesions with conventional nevic melanocytes: A case report and review of literature.
    Wysozan TR; Khelifa S; Turchan K; Alomari AK
    J Cutan Pathol; 2019 Nov; 46(11):852-857. PubMed ID: 31206729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambiguous melanocytic tumors with loss of 3p21.
    Yeh I; Mully TW; Wiesner T; Vemula SS; Mirza SA; Sparatta AJ; McCalmont TH; Bastian BC; LeBoit PE
    Am J Surg Pathol; 2014 Aug; 38(8):1088-95. PubMed ID: 24705312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of BAP1 germline mutations in cutaneous melanocytic tumors with loss of BAP1-expression: A pilot study.
    Cabaret O; Perron E; Bressac-de Paillerets B; Soufir N; de la Fouchardière A
    Genes Chromosomes Cancer; 2017 Sep; 56(9):691-694. PubMed ID: 28560743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1-associated protein (BAP1)-inactivated melanocytic tumors.
    Zhang AJ; Rush PS; Tsao H; Duncan LM
    J Cutan Pathol; 2019 Dec; 46(12):965-972. PubMed ID: 31233225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP1-inactivated melanocytic tumor with preserved BAP1 expression? Morphology to the rescue!
    Duncan LM; Tetzlaff MT
    J Cutan Pathol; 2020 May; 47(5):459-461. PubMed ID: 32096236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRAS-mutated melanocytic BAP1-associated intradermal tumor (MBAIT): a case report.
    Blokx WA; Rabold K; Bovenschen HJ; Ligtenberg MJ; Mensenkamp AR; van Lijnschoten G; van Zelst-Stams WA; Groenen PJ
    Virchows Arch; 2015 Jan; 466(1):117-21. PubMed ID: 25342144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature.
    Donati M; Šteiner P; Kazakov DV
    Am J Dermatopathol; 2023 Feb; 45(2):117-122. PubMed ID: 36669076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
    Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.